ArriVent BioPharma (AVBP) Shares Outstanding (2023 - 2026)

ArriVent BioPharma has disclosed Shares Outstanding across 4 years of filings, most recently posting $45.3 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $45.3 million, up 33.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.3 million (up 33.1% YoY), and the FY2025 annual result was $42.5 million, up 25.95% from the prior year.
• Shares Outstanding came in at $45.3 million for Q1 2026 at ArriVent BioPharma, up from $42.5 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $45.3 million in Q1 2026 to a low of $2.6 million in Q2 2023.
• The 4-year median for Shares Outstanding is $33.7 million (2024), against an average of $26.6 million.
• Across the five-year window, Shares Outstanding jumped 1187.12% in 2024 and increased 1.63% in 2025, its largest moves.
• ArriVent BioPharma's Shares Outstanding stood at $2.7 million in 2023, then soared by 1127.72% to $33.7 million in 2024, then grew by 25.95% to $42.5 million in 2025, then advanced by 6.73% to $45.3 million in 2026.
• The last three Shares Outstanding figures came in at $45.3 million (Q1 2026), $42.5 million (Q4 2025), and $40.9 million (Q3 2025), per Business Quant data.